AAAAAA
Results: 26-40/40
Authors:
Kalviainen, R
Salmenpera, T
Partanen, K
Vainio, P
Riekkinen, P
Pitkanen, A
Citation: R. Kalviainen et al., Hippocampal damage and the onset of epilepsy - Reply, NEUROLOGY, 52(8), 1999, pp. 1719-1720
Authors:
Ikonen, S
Riekkinen, P
Citation: S. Ikonen et P. Riekkinen, Effects of apamin on memory processing of hippocampal-lesioned mice, EUR J PHARM, 382(3), 1999, pp. 151-156
Authors:
Wilson, IA
Puolivali, J
Heikkinen, T
Riekkinen, P
Citation: Ia. Wilson et al., Estrogen and NMDA receptor antagonism: effects upon reference and working memory, EUR J PHARM, 381(2-3), 1999, pp. 93-99
Authors:
Ikonen, S
Schmidt, BH
Riekkinen, P
Citation: S. Ikonen et al., Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice, EUR J PHARM, 372(2), 1999, pp. 117-126
Authors:
Riekkinen, P
Ikonen, S
Aura, J
Riekkinen, M
Citation: P. Riekkinen et al., Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water mazespatial navigation defect induced by hippocampal inactivation, EUR J PHARM, 366(1), 1999, pp. 13-18
Authors:
Sivenius, J
Cunha, L
Diener, HC
Forbes, C
Laakso, M
Lowenthal, A
Smets, P
Riekkinen, P
Citation: J. Sivenius et al., Second European Stroke Prevention Study: antiplatelet therapy is effectiveregardless of age, ACT NEUR SC, 99(1), 1999, pp. 54-60
Authors:
Vanhanen, M
Kuusisto, J
Koivisto, K
Mykkanen, L
Helkala, EL
Hanninen, T
Riekkinen, P
Soininen, H
Laakso, M
Citation: M. Vanhanen et al., Type-2 diabetes and cognitive function in a non-demented population, ACT NEUR SC, 100(2), 1999, pp. 97-101
Authors:
Soininen, HS
Riekkinen, P
Citation: Hs. Soininen et P. Riekkinen, Apoe type and MRI volumetric changes as predictor of Alzheimer's disease, RESEARCH AND PRACTICE IN ALZHEIMER'S DISEASE, VOL 2, 1999, pp. 95-98
Authors:
Kuusisto, J
Koivisto, K
Mykkanen, L
Helkala, E
Vanhanen, M
Hanninen, T
Kervinen, K
Kesaniemi, YA
Riekkinen, P
Laakso, M
Citation: J. Kuusisto et al., Insulin resistance syndrome and Alzheimer's disease: The summary of Finnish studies, RESEARCH AND PRACTICE IN ALZHEIMER'S DISEASE, VOL 2, 1999, pp. 135-139
Authors:
Tapiola, T
Lehtovirta, M
Pirttila, T
Alafuzoff, I
Riekkinen, P
Soininen, H
Citation: T. Tapiola et al., Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 193-197
Authors:
Riekkinen, M
Laakso, MP
Jakala, P
Riekkinen, P
Citation: M. Riekkinen et al., Clonidine impairs sustained attention in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 641-647
Oxotremorine suppresses thalamocortical oscillations via thalamic muscarinic acetylcholine receptors
Authors:
Puolivali, J
Jakala, P
Koivisto, E
Riekkinen, P
Citation: J. Puolivali et al., Oxotremorine suppresses thalamocortical oscillations via thalamic muscarinic acetylcholine receptors, PSYCHOPHAR, 140(3), 1998, pp. 285-292
Authors:
Riekkinen, P
Ikonen, S
Riekkinen, M
Citation: P. Riekkinen et al., D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine hasno effect, NEUROREPORT, 9(16), 1998, pp. 3647-3651
Authors:
Riekkinen, P
Schmidt, BH
van der Staay, FJ
Citation: P. Riekkinen et al., Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease, ANN MED, 30(6), 1998, pp. 566-576
Authors:
Miettinen, R
Kotti, T
Tuunanen, J
Toppinen, A
Riekkinen, P
Halonen, T
Citation: R. Miettinen et al., Hippocampal damage after injection of kainic acid into the rat entorhinal cortex, BRAIN RES, 813(1), 1998, pp. 9-17